PATENT CLAIM ANALYSIS

Application Number: 15905797
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "618000"]

Abstract:
There are disclosed topical silver(II) antibiotic formulations. Other embodiments are also disclosed.

Claim (Index 18):
The method of  claim 8 , at least one of said aliphatic silver carboxylate and said carrier base selected, such that after standard ultraviolet light (UV) treatment, in which said first formulation or said silver(II) carboxylate formulation is subjected to constant exposure to UV for 12 hours at 240 nm, a standard whiteness value thereof remains within 0.5 RU of an initial standard whiteness value of the respective formulation, prior to said standard ultraviolet light (UV) treatment.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.21429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15064623', '15495560', '14176096', '12841031', '11859094']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.739444749361893
- 35 USC 102 Novelty (BERT): 0.559123634850816
- Combined Prediction Score: 0.7214126379107852
- Mean Citation Score: 274.048706
- Max Citation Score: 421.0087
- Similarity Product: 341.83855270465614

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test